@regeneron.com
Regeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
SVG
Logo
SVG
Logo
SVG
Logo
SVG
Icon
JPEG
About
Description
Regeneron Pharmaceuticals, Inc., headquartered in Tarrytown, New York, is a leading biotechnology company focused on the discovery, development, and commercialization of innovative medicines for serious medical conditions. Founded in 1988 by Leonard Schleifer, its current CEO, and scientist George Yancopoulos, Regeneron began as a small research laboratory before expanding into a full-fledged pharmaceutical company. The company's mission is to use the power of science to bring transformative treatments to people in need.
Regeneron's headquarters is located in Tarrytown, New York, where it operates a large research and development campus. The campus houses state-of-the-art laboratories and manufacturing facilities, enabling the company to conduct cutting-edge research and bring its products to market. The company's main products and services revolve around its core areas of focus, including ophthalmology, oncology, allergic and inflammatory diseases, cardiovascular diseases, and infectious diseases.
Some of its most well-known products include EYLEA, a treatment for various eye diseases, and Dupixent, a breakthrough therapy for asthma and atopic dermatitis. Regeneron operates on a global scale, with a presence in over 100 countries. The company has established numerous partnerships and collaborations to further its research and development efforts.
Notably, Regeneron has formed strategic alliances with major pharmaceutical companies, including Sanofi and Bayer. In the biotechnology sector, Regeneron holds a prominent market position. Its global sales have experienced significant growth, driven by the success of its flagship products like EYLEA and Dupixent.
The company's research and development capabilities, coupled with its strong market presence, have cemented its status as a leading player in the industry. Regeneron has achieved numerous notable achievements throughout its history. In 2020, the company gained recognition for its collaboration with Sanofi to develop a potential treatment for COVID-19.
This partnership exemplifies Regeneron's commitment to addressing global health challenges and advancing scientific breakthroughs. As of the latest updates, Regeneron continues to innovate and expand its product pipeline. The company remains dedicated to advancing its research efforts and bringing novel treatments to patients worldwide.
Regeneron's commitment to scientific excellence and patient care positions it for continued growth and success in the biopharmaceutical industry
Company Type
Public Company
Company Size
10,001+
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories